Featured Research

from universities, journals, and other organizations

University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control

Date:
March 17, 1999
Source:
University Of Pittsburgh Medical Center
Summary:
Using a patented gene vector developed by the University of Pittsburgh, a University of South Carolina-led research team is the first to show that gene therapy blocks certain pain responses in animals. This landmark study, which paves the road for future clinical research, is published in the March 16 issue of the Proceedings of the National Academy of Sciences.

PITTSBURGH, March 16 -- Using a patented gene vector developed by the University of Pittsburgh, a University of South Carolina-led research team is the first to show that gene therapy blocks certain pain responses in animals. This landmark study, which paves the road for future clinical research, is published in the March 16 issue of the Proceedings of the National Academy of Sciences.

Related Articles


"Our research results clearly show that pain-associated behaviors diminished in mice treated with a herpes virus containing a gene that triggers production of a pain-blocking protein," said Joseph Glorioso, Ph.D., developer of the gene vector and professor and chairman of the department of molecular genetics and biochemistry at the University of Pittsburgh. "Our vector continued to produce this protein up to seven weeks after it was introduced into these animals, suggesting that this therapy may provide long-term pain relief if used clinically," added Dr. Glorioso, who also directs the Pittsburgh Human Gene Therapy Center.

Steven Wilson, Ph.D., professor of pharmacology and physiology at the University of South Carolina, who initiated this project while on sabbatical at the University of Pittsburgh, led the research team. David C. Yeomans, Ph.D., of the University of Illinois at Chicago, designed and performed the experiments demonstrating production of the pain-blocking protein and its pain-preventing effects.

The research team expects that within several years this approach could be used broadly to treat debilitating pain associated with cancer, arthritis, angina and peripheral neuropathies. Currently, these problems are often treated with narcotic-based medications given systemically, which can cause generalized side effects such as mental confusion and lethargy. Moreover, they are potentially addictive and in some cases ineffective for complete relief of pain.

Specifically, Dr. Wilson's team found that the gene acted on C-type neurons, which transmit information felt as slow, burning pain by humans. This observation is particularly encouraging for future clinical applications, according to the investigators, because C-type neurons are thought to be the primary transmitters of chronic pain.

"The gene-vector-based therapy, in contrast to current pain control methods, is highly localized, and the release of the potentially pain-relieving substance is self-limiting because it is triggered only when the nerves encounter hyper-stimulation," added Dr. Wilson.

"Our engineered herpes virus used for this research is exceptionally well-suited to deliver genes for pain relief," according to Dr. Glorioso.

The herpes virus resides exclusively in neurons and does not integrate with the host cell's DNA, where it could potentially alter the function of other genes. Further, the herpes virus is capable of transporting large genes or multiple genes required to carry out biological processes, such as regulating insulin production for the treatment of diabetes or producing multiple hormones that protect neurons against the destructive effects of neuropathologic conditions, including chemotherapy-induced damage.

Experiment Details: In their experiments, the investigators used a gene for preproenkephalin. Once produced inside the body, this substance is enzymatically processed into opiate-like peptides known as enkephalins. The researchers placed the gene inside a herpes virus capable of establishing latency in the nervous system, a state where the viral genes are inactive while the enkephalin gene remains active. The researchers transferred the gene-containing virus to the paws of mice, where it naturally infected sensory neurons, including those that respond to noxious stimuli such as heat.

"These results are quite exciting, because we don't interfere with an animal?s ability to detect a noxious stimulant and react to danger," said Dr. Wilson. "Only when sensitivities to noxious stimuli are enhanced, a phenomenon that may be important in chronic pain states, does the gene therapy act, with the result that gene-treated animals respond more slowly to this hyper-stimulation than do untreated ones," he added.

For more information about the University of Pittsburgh's Human Gene Therapy Center, please access http://www.pitt.edu/~rsup/phgt.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control." ScienceDaily. ScienceDaily, 17 March 1999. <www.sciencedaily.com/releases/1999/03/990317060656.htm>.
University Of Pittsburgh Medical Center. (1999, March 17). University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/1999/03/990317060656.htm
University Of Pittsburgh Medical Center. "University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control." ScienceDaily. www.sciencedaily.com/releases/1999/03/990317060656.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins